InvestorQ : How do you see the quarterly numbers of Ajanta Pharma for Q4FY22?
Arya Nanda made post

How do you see the quarterly numbers of Ajanta Pharma for Q4FY22?

Answer
image
Anjana Aiyar answered.
7 days ago
Follow

Ajanta Pharma sales revenues were up 14.99% at Rs870.29 crore for the Mar-22 quarter. FY22 full year revenues were up 15.6% at Rs3,341 crore. For Q4FY22, India sales were 13% higher at Rs245 crore. The growth was healthy across verticals and this included cardiology (11%), ophthalmology (25%), dermatology (17%) and pain management (28%). Full year India sales were up 21%, largely driven by growth in pain management segment.

Ajanta Pharma

Rs in Crore

Mar-22

Mar-21

YOY

Dec-21

QOQ

Total Income (Rs cr)

₹ 870.29

₹ 756.84

14.99%

₹ 837.91

3.86%

Net Profit (Rs cr)

₹ 151.21

₹ 159.26

-5.05%

₹ 191.78

-21.15%

Diluted EPS (Rs)

₹ 17.70

₹ 18.40

₹ 22.16

Net Margins

17.37%

21.04%

22.89%

  

Net profit for Q4FY22 fell -5.05% at Rs151.21 crore with the pressure mounting from a sharp spike in the cost of raw material and manpower. EBITDA fell -20.1% yoy to Rs207 crore even as the EBITDA margins tapered to 24% in Q4FY22. The exports sales at Rs616 crore were largely driven by the emerging markets. Net margins stood at 17.37% in Q4FY22 compared to 21.04% in Q4FY21. The margins were lower on a sequential basis too.

3 Views